The 2026 MLB season is underway, and the Novig prediction market has priced every division race, every award chase, and every rotation battle that matters. On a peer-to-peer exchange where prices are set by real trader conviction rather than a bookmaker protecting a margin, the signal is clean. Here is what the market is saying about the races that will define the next six months, and what the early-season evidence says about whether those prices are right.
Division Winners
NL East Winner
The NL East is the tightest division race on the board, and the market is saying so directly. Atlanta at +155 is a modest favorite over a Mets squad at +201 and a Phillies team at +213.
The Braves’ price rests on roster depth and recent history. This organization has won the NL East five consecutive times and builds from a foundation of elite two-way talent. Ronald Acuña Jr., returning from back-to-back injury-impacted seasons, is the centerpiece of the Atlanta offense, and a fully healthy season from him would move this number considerably shorter. The market is pricing both his upside and his injury risk in the same breath.
The Mets at +201 are the most interesting number in the division. New York made significant offseason moves and enters 2026 with one of the deeper lineups in the National League, led by Juan Soto, who is already dealing with early-season injury concerns. If Soto is healthy for the full year, the Mets' price looks too long. Philadelphia at +213 has a lineup as settled as anyone in baseball with Bryce Harper, Trea Turner, and a rotation anchored by Cristopher Sanchez and a healthy J.T. Realmuto returning behind the plate.
The honest read from the market is that this is a three-team division and the prices reflect it. At +155, Atlanta is the market’s pick. At +201 and +213, the Mets and Phillies are both genuine value for traders who believe the Braves’ roster is not as deep as it was during their peak division-winning years.
NL Central Winner
The NL Central is another legitimate three-team race, though no team has separated themselves through pitching depth, lineup construction, and bullpen reliability the way division favorites typically do.
Chicago at +203 is the slight favorite on the back of a rotation anchored by Shota Imanaga, who stayed put this offseason, and an offense that has added pieces around a core that believes it is ready to compete. The Cubs’ price is a bet on organizational continuity and a lineup that scores enough to support their pitching.
Pittsburgh at +245 is the most compelling number in the division. Paul Skenes is the best pitcher in the National League and, by ERA over the first two seasons of his career, one of the most dominant starting pitchers in the history of the sport. A 1.97 ERA across back-to-back seasons puts him in historically rare company. His rough Opening Day start against the Mets does not change what the Pirates have in him. Pittsburgh’s ability to compete comes down to whether the lineup around Skenes can score enough to win division games. At +245, the market is giving you Skenes at a price that accounts for the offense without fully discounting him.
Milwaukee at +257 is the steady organizational choice. They are a franchise that continues to develop pitching and manufacture wins in ways that outperform their payroll. Brandon Woodruff returning healthy is the pivotal question for their rotation.
AL Central Winner
Detroit at +138 is the clearest favorite on the division board and much of that boils down to Tarik Skubal. The two-time reigning AL Cy Young Award winner posted a 2.21 ERA with 241 strikeouts in 195.1 innings last season, a 6.5 WAR campaign that was the driving force behind Detroit's second consecutive playoff appearance. Three starts into 2026, he is carrying a 2.55 ERA and looks every bit like a pitcher chasing a third Cy Young. With Framber Valdez behind him, the Tigers may have the best 1-2 rotation punch in the American League.
The Skubal question that the market is pricing in: he is a free agent after this season, with an expected contract value north of $400 million. If Detroit stumbles, he becomes the most valuable trade deadline asset in baseball. That uncertainty around if Skubal will be a Tiger for the whole season is the one number that could move this division market dramatically.
Kansas City at +273 is the market's respect for Bobby Witt Jr., the most complete position player in the AL outside of Aaron Judge. Cleveland at +279 is almost identical, which correctly reflects the Guardians’ organizational pitching development machine and Jose Ramirez anchoring the lineup. These two teams are priced as essentially the same and that is probably the right call.
NL West Winner
The Los Angeles Dodgers are the obvious missing team here, and the gap between their implied probability and the rest of the field tells you everything about what the market thinks of this division. With Shohei Ohtani fully healthy as a two-way player for the first time since 2023, a rotation that includes Yoshinobu Yamamoto, and a lineup built around Mookie Betts and Freddie Freeman, the Dodgers are the prohibitive favorites to win the NL West.
San Diego at +1329 is the only realistic challenger. The Padres’ rotation gives them a legitimate pitching foundation. The question for San Diego is always if the offense can give the pitching enough support to stay within striking distance of Los Angeles over 162 games.
Arizona at +3233 and San Francisco at +4067 are teams with real rosters and players, but the gap between them and the Dodgers is large. The market is pricing that gap correctly.
AL West Winner
The sharpest number on the entire board. Seattle at +102 to win their own division is the market saying this is a coin flip. When a division favorite is priced at plus odds, it means real money has come in questioning the price.
The Mariners finished just six outs from the 2025 World Series and return with a full season of Josh Naylor and All-Star Brendan Donovan added to one of baseball's elite pitching staffs. Bryan Woo anchors a rotation with legitimate depth, and this organization has built a pitching infrastructure that consistently outperforms expectations.
Texas at +227 is the value play for traders who believe in the Rangers' retooling. They brought in Skip Schumaker as manager, added offensive pieces, and beefed up the rotation with Jacob deGrom headlining. They put up the run differential of a 90-win team in 2025 while finishing 81-81. That gap between performance and results is exactly what traders look for in a bounce-back candidate. At +227, the market is giving you significant return on a team that may be better than its record suggests.
Houston at +646 reflects a franchise in transition following the departures of key rotation pieces. Oakland at +706 is a rebuilding organization with more young talent than their record typically shows.
AL East Winner
The second division on the board where the favorite is priced at plus odds. New York at +104 reflects a market that sees an AL East race rather than a coronation. The Yankees are the slight favorite on the strength of Aaron Judge, but early signs in 2026 have Judge off to a slower-than-expected start at .237/.326/.500 through 10 games.
Baltimore at +415 is a franchise that has built one of the deepest rosters in the American League through the draft. Jackson Holliday, Jordan Westburg, Gunnar Henderson, and Adley Rutschman give the Orioles a young core that competes for the next decade. Both Holliday and Westburg opened the season on the injured list, which is the main reason the market has them at this price rather than shorter.
Toronto at +521 is the organization that made the boldest pitching additions of any AL East team this offseason. Dylan Cease headlining a rotation that already includes Kevin Gausman gives the Blue Jays genuine dual-ace credibility. Boston at +562 is a team in active development, with Roman Anthony and Marcelo Mayer representing the upside that moves their price off the longest odds in the division.
MVP Winners
AL MVP
Aaron Judge is the favorite at +204, which is the market saying he is the most likely winner while leaving meaningful room for the field. Judge has won three AL MVPs in four seasons and led the majors last year in WAR, batting average, on-base percentage, slugging, and OPS. The case against him winning a fourth is not about his talent, it’s about whether a slow start becomes a trend, and whether one of the game's other elite players finally has the season that the voters cannot ignore.
Bobby Witt Jr. at +549 is the most compelling alternative. He has finished second to Judge and was the primary challenger heading into 2026. Over the past two seasons, Witt is the only player in the majors with a batting average over .300 and at least 50 home runs and 50 stolen bases combined. His defense adds a dimension Judge simply does not have. The market at +549 is offering real value on a player multiple analysts have called the AL's best all-around position player.
Gunnar Henderson at +625 is the long-term upside play. The Orioles shortstop has the tools to win an MVP in any season he stays healthy and the Baltimore lineup gives him protection. Yordan Alvarez at +675 represents a player whose offensive ceiling in a full healthy season could dominate any race he enters.
NL MVP
The market is not treating this as a race. Ohtani at -203 is a near-certainty in the eyes of traders, and the evidence backs it up. Ohtani has four MVPs in five seasons, all unanimous, and 2026 marks the first year since 2023 that he will be fully active as both a pitcher and a hitter at the peak of his powers. Early returns through 11 games, a .286/.407/.524 slash line with six scoreless innings in his first pitching start, suggest he is exactly where he needs to be.
The counterargument that the market has marginally priced is that Ohtani's pitching workload will be managed, as it always is, and a significant injury to his arm or his body could shift the race. That scenario is reflected in the +1308 on Acuña and +1624 on Soto, both of whom are already dealing with health questions in April. Corbin Carroll at +1463 is the alternative for traders who believe in the Diamondbacks shortstop following his career-high 31 homer season in 2025.
If you are looking for value in this market, the honest answer is that there is very little at -203 for Ohtani. The price is where it is because the market is right.
AL Cy Young Winner
Skubal at +200 is the shortest Cy Young price on either board and the easiest case to make in either league. Skubal already has two consecutive AL Cy Young Awards. A 2.21 ERA last season with 241 strikeouts. A 2.55 ERA three starts into 2026. The question is not whether Skubal is the best pitcher in the American League, but whether the ballot will look the same come October as it does in April. The free agency question compounds the narrative. If the Tigers trade him in July, he pitches a partial season in two cities, which historically complicates Cy Young voting.
Bryan Woo at +953 is the most interesting alternative. The Mariners' ace enters 2026 as the centerpiece of one of the deepest pitching organizations in baseball, and his stuff gives him genuine breakout potential. At nearly 10-to-1, Woo represents real value if you believe in his trajectory.
Jacob deGrom at +1718 is the dream scenario for the Rangers. He is a healthy deGrom leading a retooled rotation, reminding the league what he was before injuries cost him significant time. The market is pricing the uncertainty around his durability directly. If he pitches 180-plus innings healthy, +1718 becomes a number people talk about in October. If he misses time again, the price will look about right.
Garrett Crochet at +1539 is worth watching for Boston traders. The Red Sox left-hander's pure stuff puts him in elite company, and a full, healthy season in Boston's rotation could produce numbers that force the ballot conversation.
NL Cy Young Winner
The tightest award market on the board. Skenes at +346, Sanchez at +365, and Yamamoto at +418 are essentially priced as a three-way toss-up, and that reflects the uncertainty of a race without a dominant incumbent.
Skenes is the defending NL Cy Young winner. His 1.97 ERA last season was the first sub-2.00 ERA for a starting pitcher since Justin Verlander in 2022. His rough Opening Day start gave early skeptics material, but the underlying profile remains historic. A pitcher with a career 1.97 ERA through his first 55 starts does not become average in year three.
Sanchez at +365 is the case for Philadelphia. The Phillies left-hander has developed into one of the most effective starters in the National League, and pitching in a lineup that scores runs consistently gives him a win total advantage that voters historically reward. At essentially the same price as Skenes, the market is saying these two are indistinguishable entering the season.
Yamamoto at +418 is the Dodgers floor. He is pitching behind the best offense in the National League, in a rotation built to protect him, for a franchise that develops pitching better than anyone in the game. The gap between his price and the top two is thin enough that any early momentum in his direction could shift the market quickly.
Mason Miller at +817 is the most interesting long shot on this board. The Athletics reliever, or potential starter, has stuff that belongs in any conversation about the best pitching in the game. His path to a Cy Young is narrow but not impossible.
Ohtani at +1487 on the NL Cy Young is the market acknowledging that his pitching output alone could win an award that is not already claimed by his bat. If he reaches 180 innings and maintains his historical rate of excellence on the mound, +1487 is a number worth a small position.
The Bottom Line
The Novig market has drawn clear lines heading into the 2026 season. Ohtani at -203 for NL MVP is the most closed market in baseball right now. Skubal at +200 for AL Cy Young is the market’s most confident pitching call. The NL Cy Young three-way race between Skenes, Sanchez, and Yamamoto is the most uncertain award market of the season, as all three prices represent real value on a race that could go in any direction.
On a no-commission exchange like Novig, every price you see is real market consensus, not a house number built to protect margin. Six months of baseball separates the market from the answers. Trade your read on the 2026 season at true odds on Novig.
